10-Year Benefit With FFR-Guided Complete Revascularization for STEMI

(MedPage Today) -- For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the DANAMI-3-PRIMULTI trial brought greater assurance that complete revascularization has clinical benefits.
At...